NIP
SAGE

Nicholas Investment Partners’s Sage Therapeutics SAGE Stock Holding History

Nicholas Investment Partners’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-105,771
Closed -$6.46M – 187
2020
Q3 		$6.46M Buy
+105,771
New +$5.36M 0.7% 51
2019
Q4 		– Sell
-59,761
Closed -$8.38M – 232
2019
Q3 		$8.38M Sell
59,761
-17,855
-23% -$2.99M 0.71% 35
2019
Q2 		$14.2M Sell
77,616
-2,562
-3% -$437K 1.3% 9
2019
Q1 		$12.8M Buy
80,178
+26,815
+50% +$3.88M 1.14% 11
2018
Q4 		$5.11M Sell
53,363
-25,813
-33% -$2.95M 0.55% 55
2018
Q3 		$11.2M Sell
79,176
-1,818
-2% -$281K 0.9% 18
2018
Q2 		$12.7M Buy
80,994
+19,048
+31% +$2.99M 0.89% 9
2018
Q1 		$9.98M Buy
61,946
+22,894
+59% +$3.89M 0.71% 15
2017
Q4 		$6.43M Sell
39,052
-3,121
-7% -$303K 0.43% 53
2017
Q3 		$2.63M Sell
42,173
-33,632
-44% -$2.64M 0.18% 188
2017
Q2 		$6.04M Sell
75,805
-254
-0.3% -$18.4K 0.43% 54
2017
Q1 		$5.41M Sell
76,059
-11,100
-13% -$650K 0.38% 78
2016
Q4 		$4.45M Buy
87,159
+15,676
+22% +$739K 0.34% 112
2016
Q3 		$3.29M Buy
+71,483
New +$2.91M 0.22% 184
2016
Q2 		– Sell
-58,580
Closed -$1.88M – 327
2016
Q1 		$1.88M Sell
58,580
-3,209
-5% -$113K 0.14% 241
2015
Q4 		$3.6M Sell
61,789
-7,338
-11% -$364K 0.25% 172
2015
Q3 		$2.92M Buy
69,127
+12,375
+22% +$763K 0.21% 202
2015
Q2 		$4.14M Buy
56,752
+506
+0.9% +$32.5K 0.27% 136
2015
Q1 		$2.83M Sell
56,246
-8,940
-14% -$384K 0.18% 220
2014
Q4 		$2.39M Buy
65,186
+1,001
+2% +$37.3K 0.15% 229
2014
Q3 		$2.02M Buy
+64,185
New +$1.86M 0.13% 239

Other funds holding SAGE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nicholas Investment Partners's SAGE Position: Q4 2020 in Review

Nicholas Investment Partners sold out of Sage Therapeutics (SAGE) in Q4 2020, closing a stake of 105,771 shares — an estimated $6.46M sold.

Nicholas Investment Partners first reported a position in SAGE in Q3 2014 and held it in 21 quarters. The position peaked at $14.2M in Q2 2019. 249 funds tracked by Wall St. Rank hold SAGE as of Q4 2020.

  • Nicholas Investment Partners reported no remaining Sage Therapeutics position as of Q4 2020 after selling out during the quarter.
  • Nicholas Investment Partners sold 105,771 Sage Therapeutics shares in Q4 2020, an estimated $6.46M.
  • Nicholas Investment Partners first reported a position in Sage Therapeutics in Q3 2014 and held it in 21 quarters.
  • Nicholas Investment Partners's Sage Therapeutics position peaked at $14.2M in Q2 2019.
  • 249 funds tracked by Wall St. Rank held Sage Therapeutics as of Q4 2020.

Based on Nicholas Investment Partners's 13F filing for Q4 2020, filed 11 Feb 2021.